GEN Exclusives

More »

GEN News Highlights

More »
Mar 28, 2007

Pharmacopeia Pockets $1M Milestone Payment from Schering-Plough

  • Schering-Plough initiated a Phase I evaluation of an anti-inflammatory compound identified in collaboration with Pharmacopeia. The company will thus receive a $1-million milestone payment from Schering-Plough.

    "With four product candidates in clinical development, our collaboration with Schering-Plough is currently our most productive," comments Les Browne, Ph.D., president and CEO of Pharmacopeia.

    Schering-Plough is solely responsible for further development and commercialization of the candidate. Pharmacopeia is eligible to receive additional milestone payments based on clinical advancement and royalties on sales of any resulting therapeutic products incorporating compounds derived from the program.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Should the CDC Director Resign?

Do you think the CDC chief should resign?